- Sucralfate is an
oral gastrointestinal medication primarily indicated for the treatment
of active duodenal ulcers.
- It is also used for
the treatment of gastroesophageal reflux disease and stress ulcers.
- Sucralfate requires
stomach acid in order to form its protective gel.
- sucralfate is a
sucrose sulfate-aluminium complex that binds to the hydrochloric acid in
the stomach and acts like an acid buffer with cytoprotective
properties.
- Sucralfate is a
locally acting substance that in an acidic environment, reacts with
hydrochloric acid in the stomach to form a cross-linking, viscous,
paste-like material capable of acting as an acid buffer for as long as 6
to 8 hours after a single dose.
- Sucralfate must be
given four times daily in order to provide a continuous protective layer
on the ulcer.
- This is an
inconvenient schedule but if doses are skipped, the ulcer goes
unprotected for that period of time.
- It also attaches to
proteins on the surface of ulcers, such as albumin and fibrinogen, to
form stable insoluble complexes.
- Sucralfate has been
used in the treatment of oral, esophageal, gastric and duodenal ulcers.
- It has also been
employed to prevent drug-induced gastric erosions.
- Sucralfate may be
used in any condition associated with stomach ulceration.
- Common examples
include toxin ingestion, kidney failure, liver failure, certain forms of
cancer, and megaesophagus .
|
Introduction
- Sucralfate
- Information
about Sucralfate
- Sucralfate
Details
- Sucralfate
Background
Process
-
The Effect of Residual Water on
Antacid Properties of Sucralfate Gel Dried by Microwaves
-
Efficacy of Sucralfate in the
Postoperative Management of Uvulopalatopharyngoplasty
-
Effect of Sucralfate on Antibiotic
Therapy for
Helicobacter pylori
Infection in Mice
Effect of Drying Methods on
Retention of Moist Sucralfate Gel Properties
-
Sucralfate
Description
Application
-
Chemical Aspects of Labeling
Sucralfate
-
Guideline on the Use of Ipecac Syrup
in the Out-of-Hospital Management of Ingested Poisons
-
Influence of Intravenously
Administered Ciprofloxacin on Aerobic Intestinal Microflora and Fecal
Drug Levels When Administered Simultaneously with Sucralfate
-
Use of probiotics for prevention of
radiation-induced diarrhea
-
The Novel Tubulin-binding Drug BTO-956
Inhibits R3230Ac Mammary Carcinoma Growth and Angiogenesis in
Fischer
-
Sucralfate
Consultant
-
Consultant From USA
-
Consultant
From UK
-
Consultant
From USA
-
Consultant
From Florida
-
Consultant
From US
-
Consultant
From Saudi Arabia
|
Product &
Msds
-
Sucralfate
-
Carafate
-
Sucralfate Products
-
Sucralfate, Fine Powder
-
Sucralfate
-
Sucralfate Tablets
Market
& Report
-
Market Penetration analysis
-
Implications for Physician Authority
and Market Structure
-
Gastric Antral Vascular Ectasia A Case
Report and Review of the Literature
-
Esophagitis Caused by Ciprofloxacin;A
Case Report and Review of the Literature
-
Right colon and liver hemangiomatosis:
A case report and a review of the literature
-
Solitary Rectal Ulcer in a Child
Treated with Local Sulfasalazine
Patent
-
Sucralfate Containing Composition
& Process for the preparation Thereof
-
Formulation of sucralfate
-
Melt Granulated Sucralfate Preparation
& a Process For Their Production
-
Pharmaceutical Composition Containing
Sucralfate
-
Sucralfate Preparations
-
Use of Sucralfate For controlling
Emises and or Diarrhea
Hazards
-
View of Carafate Tablets Side
Effects
-
Side Affect of Generic for
Sucralfate
Order the CD ROM
Today
|